+987.9%
MRNA vs ED
+27.1%
+960.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ED | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +3.0% | +10.1% | +15.4% |
| 7D | +20.6% | +5.4% | +15.3% | +25.6% |
| 30D | +27.1% | +16.4% | +10.8% | +43.4% |
| 3M | +353.4% | +11.9% | +341.5% | +399.6% |
| 6M | +446.3% | +11.6% | +434.7% | +507.2% |
| YTD | +776.2% | +24.1% | +752.1% | +844.0% |
| 1Y | +987.9% | +26.9% | +961.0% | +1,056.4% |
| All | +987.9% | +27.1% | +960.8% | +1,056.4% |
Cumulative growth
Daily Returns
Daily percentage return beside ED.
Daily Out/Under-Performance
Portfolio return minus ED return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ED return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ED wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling